Multiple Sclerosis Info
View Article  Mitoxantrone in MS Show Good Safety and Tolerability
Five-year cardiac and haematological data from a large cohort of multiple sclerosis (MS) patients show that mitoxantrone is generally well tolerated and safe. The results on mitoxantrone, which is routinely used in   more »
View Article  NICE Recommends TYSABRI® for Use in Highly Active Relapsing Remitting Multiple Sclerosis

NICE Recommends TYSABRI® for Use in Highly Active Relapsing Remitting Multiple Sclerosis

 

Final Guidance Issued on First MS Treatment Recommended by NICE

 

MAIDENHEAD, ...   more »

View Article  Rebif & Influenza Vaccine

"Immune Response to Influenza Vaccine is Maintained in MS Patients Treated With Rebif (interferon beta-1a)"

 

November 10, 2005 –

 

Data presented at:

XVIIIth World Congress of Neurology in ...   more »

View Article  Copaxone - long term use safe
Long-term Use of Glatiramer Acetate (Copaxone) for Multiple Sclerosis Appears Safe and Efficacious: Presented at ECTRIMS By Bruce Sylvester THESSALONIKI, GREECE – September 30, 2005 – Patients with relapsing-remitting multiple ...   more »
View Article  Interferon Beta-1b Delays Development of MS

BENEFIT Study Shows Interferon Beta-1b Delays Development of MS in Patients with First Clinical Signs of Disease

 

BASEL, SWITZERLAND -- October 14, 2005 –

 

Interferon beta-1b 250 mcg* ...   more »

View Article  Early Interferon Beta-1b Treatment Thwarts MS Progression

U.S. FDA Approves Betaseron(R) (Interferon beta-1b) for Use After the First Event Suggestive of Multiple Sclerosis

 

Early Treatment With Betaseron Significantly Delayed the Time ...   more »

View Article  Early Treatment With Betaseron Significantly Delayed the Time to a Second Clinical Event
Using interferon beta-1b (Betaseron) therapy in patients with the first clinical symptoms of MS (MS) significantly postpones the development of   more »
View Article  Patients Treated With Betaseron(R) After First MS Attack

Landmark Study in The Lancet:

 

Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression

 

 WAYNE, N.J.,

 ...   more »

View Article  Glatiramer Acetate (Copaxone) Injections Reduced Relapses by 75%

Glatiramer Acetate Injections Reduced Relapses by 75% in Both Treatment-Naïve Multiple Sclerosis Patients and Those Failing Interferon Beta-1bMore than 80% of All Patients Experienced an ...   more »

View Article  Join Shared Solutions with Copaxone

Join Shared Solutions®

 

Become a Member in Canada

Shared Solutions® is a free comprehensive multiple sclerosis (MS) patient support program. When you ...   more »

View Article  New AVONEX(R) Nurse Services Program

Biogen Idec Launches New AVONEX(R)

Nurse Services Program

   

CAMBRIDGE, Mass.—

 

Biogen Idec announced today the national launch of the new
AVONEX(R) (Interferon beta-1a) ...   more »